IPHA Innate Pharma

Watchlist

Trading Apr 29 09:30 ET

200.49MMarket Cap-25833P/E (TTM)

Innate Pharma Stock Analyst Ratings & Price Target

Updated: Apr 16, 2024

Based on 2 analysts giving stock ratings to Innate Pharma in the past 3 months

Buy

Updated: Apr 16, 2024

The average Innate Pharma stock price target is 11.50 with a max estimate of 11.50 and a min estimate of 11.50

Review Innate Pharma earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 16, 2024

Buy

Updated: Apr 16, 2024

Overall